Xeris Pharmaceuticals | XERS - Fremdkapital

Aktienkurs
5.92
Täglich Wechseln
-0.09 -1.50%
Monatlich
-5.28%
Jährlich
16.54%
Q2 Prognose
6.11




Fremdkapital Veränderung Datum
Celltrion KRW 412.27B 348.97B 2025-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Eli Lilly USD 39.37B 1.5B 2026-03
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.62B 17.5M 2026-03
Pharma Mar EUR 33.16M 3.52M 2026-03
Qiagen NV USD 1.65B 15.23M 2025-12
Sartorius EUR 3.34B 152.8M 2026-03
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03